Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

Recruiting Observational Study
Neuromuscular Blockade Anesthesia, General
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
199 (estimated)
Sponsor
Ankara University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
It is known that deep neuromuscular block improves surgical conditions, especially during laparoscopic abdominal surgery. Based on this, in the Perioperative Neuromuscular Blockade Management guide published by the ESAIC association in 2022, it is recommended to deepen the level of neuromuscular blockade in cases where surgical conditions need to be improved. Sugammadex should be used to quickly a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: 18 - 65 (not including 65) * BMI: 18.5-24.9 Exclusion Criteria: * Liver and kidney disease * Non-consenting * Emergency surgeries * Muscle disease * Allergy to rocuronium and sugammadex * Patients predicted to have difficult mask ventilation or difficult intubation * Pr…
Contacts

Hatice Güneş Yeşilova, 1

+905510495354

htcguness@hotmail.com

CONTACT

Menekşe Özçelik, 2

+905333521400

mozcelik@ankara.edu.tr

CONTACT